Literature DB >> 22307216

Pharmacokinetics of memantine in rats and mice.

Maria G Beconi1, David Howland, Larry Park, Kathryn Lyons, Joseph Giuliano, Celia Dominguez, Ignacio Munoz-Sanjuan, Robert Pacifici.   

Abstract

Entities:  

Year:  2011        PMID： 22307216      PMCID： PMC3269340.1          DOI： 10.1371/currents.RRN1291

Source DB:  PubMed          Journal:  PLoS Curr        ISSN： 2157-3999


× No keyword cloud information.
  14 in total

1.  Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).

Authors:  J J Miguel-Hidalgo; X A Alvarez; R Cacabelos; G Quack
Journal:  Brain Res       Date:  2002-12-20       Impact factor: 3.252

2.  Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity.

Authors:  Srinivasa Subramaniam; Katherine M Sixt; Roxanne Barrow; Solomon H Snyder
Journal:  Science       Date:  2009-06-05       Impact factor: 47.728

Review 3.  Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum).

Authors:  Srinivasa Subramaniam; Solomon H Snyder
Journal:  Neuropharmacology       Date:  2010-10-31       Impact factor: 5.250

4.  Pharmacokinetic study of memantine in healthy and renally impaired subjects.

Authors:  Antonia Periclou; Daniel Ventura; Niranjan Rao; Wattanaporn Abramowitz
Journal:  Clin Pharmacol Ther       Date:  2006-01       Impact factor: 6.875

Review 5.  Selective neuronal degeneration in Huntington's disease.

Authors:  Catherine M Cowan; Lynn A Raymond
Journal:  Curr Top Dev Biol       Date:  2006       Impact factor: 4.897

6.  Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease.

Authors:  Jacqueline Shehadeh; Herman B Fernandes; Melinda M Zeron Mullins; Rona K Graham; Blair R Leavitt; Michael R Hayden; Lynn A Raymond
Journal:  Neurobiol Dis       Date:  2005-09-13       Impact factor: 5.996

Review 7.  The dichotomy of NMDA receptor signaling.

Authors:  Sofia Papadia; Giles E Hardingham
Journal:  Neuroscientist       Date:  2007-12       Impact factor: 7.519

8.  Memantine pharmacotherapy: a naturalistic study using a population pharmacokinetic approach.

Authors:  Johannes Kornhuber; Evelin M Kennepohl; Stefan Bleich; Jens Wiltfang; Thomas Kraus; Udo Reulbach; Ingolf Meineke
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

9.  Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.

Authors:  Ming-Yan Liu; Sheng-Nan Meng; Hui-Zhe Wu; Shuang Wang; Min-Jie Wei
Journal:  Clin Ther       Date:  2008-04       Impact factor: 3.393

10.  Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin.

Authors:  Shu-ichi Okamoto; Mahmoud A Pouladi; Maria Talantova; Dongdong Yao; Peng Xia; Dagmar E Ehrnhoefer; Rameez Zaidi; Arjay Clemente; Marcus Kaul; Rona K Graham; Dongxian Zhang; H-S Vincent Chen; Gary Tong; Michael R Hayden; Stuart A Lipton
Journal:  Nat Med       Date:  2009-11-15       Impact factor: 53.440
View more
  21 in total

1.  Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.

Authors:  Nathan G Glasgow; Nadezhda V Povysheva; Andrea M Azofeifa; Jon W Johnson
Journal:  J Neurosci       Date:  2017-09-06       Impact factor: 6.167

2.  Administration of memantine during withdrawal mitigates overactivity and spatial learning impairments associated with neonatal alcohol exposure in rats.

Authors:  Nirelia M Idrus; Nancy N H McGough; Edward P Riley; Jennifer D Thomas
Journal:  Alcohol Clin Exp Res       Date:  2014-01-15       Impact factor: 3.455

3.  Memantine rescues transient cognitive impairment caused by high-molecular-weight aβ oligomers but not the persistent impairment induced by low-molecular-weight oligomers.

Authors:  Cláudia P Figueiredo; Julia R Clarke; José Henrique Ledo; Felipe C Ribeiro; Carine V Costa; Helen M Melo; Axa P Mota-Sales; Leonardo M Saraiva; William L Klein; Adriano Sebollela; Fernanda G De Felice; Sergio T Ferreira
Journal:  J Neurosci       Date:  2013-06-05       Impact factor: 6.167

4.  Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats.

Authors:  Shawn E Kotermanski; Jon W Johnson; Edda Thiels
Journal:  Pharmacol Biochem Behav       Date:  2013-05-08       Impact factor: 3.533

5.  Pharmacokinetics and tissue distribution of hydrazinocurcumin in rats.

Authors:  Sumeet Gupta; Hira Choudhury; Shery Jacob; Anroop B Nair; Meenakshi Dhanawat; Kavita Munjal
Journal:  Pharmacol Rep       Date:  2021-07-20       Impact factor: 3.024

6.  Effects of Melandrium firmum Rohrbach on RANKL‑induced osteoclast differentiation and OVX rats.

Authors:  Minsun Kim; Jae-Hyun Kim; Sooyeon Hong; Boguen Kwon; Eun-Young Kim; Hyuk-Sang Jung; Youngjoo Sohn
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

7.  Memantine has no effect on KATP channels in pancreatic β cells.

Authors:  Ryota Imai; Shingen Misaka; Shoichiro Horita; Shoko Yokota; Rie O'hashi; Yuko Maejima; Kenju Shimomura
Journal:  BMC Res Notes       Date:  2018-08-25

8.  In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer's Disease.

Authors:  Elena Schartmann; Sarah Schemmert; Nicole Niemietz; Dominik Honold; Tamar Ziehm; Markus Tusche; Anne Elfgen; Ian Gering; Oleksandr Brener; Nadim Joni Shah; Karl-Josef Langen; Janine Kutzsche; Dieter Willbold; Antje Willuweit
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  Development of a Dynamic Physiologically Based Mechanistic Kidney Model to Predict Renal Clearance.

Authors:  Weize Huang; Nina Isoherranen
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-08-11

10.  Pharmacokinetic Drug-Drug Interaction and Responsible Mechanism between Memantine and Cimetidine.

Authors:  Young A Choi; Im-Sook Song; Min-Koo Choi
Journal:  Pharmaceutics       Date:  2018-08-06       Impact factor: 6.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.